Ken Griffin's position in BridgeBio Pharma is currently worth $16.6 Million. That's 0.02% of their equity portfolio (871st largest holding). The first BridgeBio Pharma trade was made in Q2 2019. Since then Ken Griffin bought shares twelve more times and sold shares on four occasions. The stake costed the investor $7.6 Million, netting the investor a gain of 118% so far.